Comparison of continuous and intermittent renal replacement therapy for acute renal failure

Nephrology Dialysis Transplantation

Volumn 20, Issue 8, 2005, Pages 1630-1637

  Uehlinger, Dominik E ^a   Jakob, Stephan M ^b   Ferrari, Paolo ^a   Eichelberger, Markus ^a   Huynh Do, Uyen ^a   Marti, Hans Peter ^a   Mohaupt, Markus G ^a   Vogt, Bruno ^a   Rothen, Hans Ulrich ^b   Regli, Bruno ^b   Takala, Jukka ^b   Frey, Felix J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute renal failure; Haemodiafiltration; Haemodialysis; Organ failure; Randomized clinical trial

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTINUOUS HEMODIAFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TECHNIQUE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMODIAFILTRATION; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; LENGTH OF STAY; MALE; MIDDLE AGED; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UREMIA; VASOCONSTRICTOR AGENTS;

EID: 26444463427     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh880     Document Type: Article

References (20)

1. Jakob SM, Frey FJ, Uehlinger DE. Does continuous renal replacement therapy favourably influence the outcome of the patients? Nephrol Dial Transplant 1996; 11: 1250-1255
2. Mehta RL, McDonald B, Gabbai FB et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60: 1154-1163
3. Suistomaa M, Kari A, Ruokonen E, Takala J. Sampling rate causes bias in APACHE II and SAPS II scores. Intensive Care Med 2000; 26: 1773-1778
4. Atkinson AC. Optimum biased-coin designs for sequential treatment allocation with covariate information (including discussion). Stat Med 1999; 18: 1741-1755
5. Fleiss JL, Tytun A, Ury HK. A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 1980; 36: 343-346
6. Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001; 29: 1910-1915
7. Gasche Y, Pascual M, Suter PM, Favre H, Chevrolet JC, Schifferli JA. Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant 1996; 11: 117-119
8. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10: 846-853
9. Sieberth HG, Kierdorf HP. Is cytokine removal by continuous hemofiltration feasible? Kidney Int Suppl 1999; 72: S79-S83
10. Vishwanath BS, Fux CA, Uehlinger DE, Frey BM, Franson RC, Frey FJ. Haemodialysis activates phospholipase A2 enzyme. Nephrol Dial Transplant 1996; 11: 109-116
11. Varela MP, Kimmel PL, Phillips TM, Mishkin GJ, Lew SQ, Bosch JP. Biocompatibility of hemodialysis membranes: Interrelations between plasma complement and cytokine levels. Blood Purif 2001; 19: 370-379
12. Cianciolo G, Stefoni S, Donati G et al. Intra- and post-dialytic platelet activation and PDGF-AB release: Cellulose diacetate vs polysulfone membranes. Nephrol Dial Transplant 2001; 16: 1222-1229
13. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305: 1176-1181
14. Gotch FA, Levin NW, Port FK, Wolfe RA, Uehlinger DE. Clinical outcome relative to the dose of dialysis is not what you think: The fallacy of the mean. Am J Kidney Dis 1997; 30: 1-15
15. Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356: 26-30
16. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305-310
17. Uchino S, Bellomo R, Ronco C. Intermittent versus continuous renal replacement therapy in the ICU: Impact on electrolyte and acid-base balance. Intensive Care Med 2001; 27: 1037-1043
18. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331: 1338-1342
19. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 1994; 344: 570-572
20. Shaldon S. Biocompatible membranes in acute renal failure: Prospective case-controlled study. Nephrol Dial Transplant 1997; 12: 235-236